2Berger F, ct al. Prevent Events J S, Roncaglioni M C, hvanzini Aspirin for the Primary ion of in Women Specific Meta Ran2domized Cont Cardiovascular and Men2A Sex2 2 analysis of rolled Trials[J]. JAblh, 2006, 295:306 - 313.
7Born GV. Aggregati on blood platelets by adenos diphosphate and its reversal Nature, 1962,194:927-929.
8Gachet C. Regulati on of functions by P2 receptors[J] of ine [J]. platelet Annu RevPharmacol Toxico, 2006, 46:277 - 300.
9VialC, Hechler B, LeonC, et nl. Presence of P2X1 purinoceptors in human platelets and megakaryoblastic celllines [J]. Thromb, Haemos t, 1997, 78: 1500 - 1504.
10SAVI P. Role of P2Y1 purinocept or in ADP-induced platelet activat ion [J]. FEBS Lett, 1998, 422: 291- 295.
3Antithrombotic Trialists′ Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86.
4Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events.The SALT Collaborative Group.Lancet,1991,338:1345-1349.
5European Stroke Prevention Study 2.Efficacy and safety data.J Neurol Sci,1997,151 Suppl:S1-S77.
6Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke.EAFT (European Atrial Fibrillation Trial) Study Group.Lancet,1993,342:1255-1262.
7Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304.
8The International Stroke Trial (IST):a randomised trial of aspirin,subcutaneous heparin,both,or neither among 19435 patients with acute ischaemic stroke.International Stroke Trial Collaborative Group.Lancet,1997,349:1569-1581.
9CAST:randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke.CAST (Chinese Acute Stroke Trial) Collaborative Group.Lancet,1997,349:1641-1649.
10Mousa SA. Antiplatelet therapies: from aspirin to GP Ⅱ b/Ⅲ a-receptor antagonists and beyond[J].Drug Discov Today,1999,4(12):522-561
